| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/16/2009 | CA2340898C Compositions and methods for treating intracellular infections |
| 06/16/2009 | CA2330500C Pharmaceutical compositions capable of being gelled |
| 06/16/2009 | CA2304975C Stabilized preparations for use in metered dose inhalers |
| 06/16/2009 | CA2243201C Process for producing sustained-release preparation |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073835A1 Oral compositions of abt-263 for treating cancer |
| 06/11/2009 | WO2009073809A2 Carbohydrate conjugates as delivery agents for oligonucleotides |
| 06/11/2009 | WO2009073546A2 Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7) |
| 06/11/2009 | WO2009073533A2 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 06/11/2009 | WO2009073524A2 Conjugates of anti-rg-1 antibodies |
| 06/11/2009 | WO2009073517A2 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 06/11/2009 | WO2009073508A2 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 06/11/2009 | WO2009073445A2 Biocompatible biodegradable fumagillin analog conjugates |
| 06/11/2009 | WO2009073192A2 Systems and methods for delivery of materials |
| 06/11/2009 | WO2009073154A1 Oligomer-tricyclic conjugates |
| 06/11/2009 | WO2009072657A1 Nanofunctional silica particles and manufacturing method thereof |
| 06/11/2009 | WO2009072629A1 Skin external preparation |
| 06/11/2009 | WO2009072572A1 Edible film |
| 06/11/2009 | WO2009072334A1 Core particle for pharmaceutical preparation |
| 06/11/2009 | WO2009072146A1 Biocompatible and biodegradable biopolymer matrix |
| 06/11/2009 | WO2009072136A1 Particulate drug carriers as desensitizing agents |
| 06/11/2009 | WO2009071731A1 Use of an ionic complex of gentamicin : aot for the treatment of brucellosis |
| 06/11/2009 | WO2009071730A1 Composition comprising gentamicin, an anionic surfactant and a copolymer |
| 06/11/2009 | WO2009071034A1 Pharmaceutical cyclosporine composition and method for altering the solubility and stability thereof |
| 06/11/2009 | WO2009070979A1 An oral cavity rapid release preparation and its preparation method |
| 06/11/2009 | WO2009070978A1 An oral cavity rapid release of the health products and its preparation method |
| 06/11/2009 | WO2009053937A3 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 06/11/2009 | WO2009050738A3 An orally administerable solid pharmaceutical composition and a process thereof |
| 06/11/2009 | WO2009049820A3 Amorphous formulation |
| 06/11/2009 | WO2008098788A3 Receptor and antigen targeted prodrug |
| 06/11/2009 | WO2007016371A3 Readily shapeable xerogels having controllably delayed swelling properties |
| 06/11/2009 | WO2003011214A3 Novel methods and formulations for administration of active agents |
| 06/11/2009 | US20090149831 Polymeric Microspheres for Treatment of Obesity |
| 06/11/2009 | US20090149639 A Simplified Method To Retrieve Chitosan From Acidic Solutions Thereof |
| 06/11/2009 | US20090149556 Non-Tumorigenic Ointment/Cream Base for Topical Application |
| 06/11/2009 | US20090149555 Method for preparing polyhydroxyalkanoates, polymers thus obtained, compositions comprising them and their uses |
| 06/11/2009 | US20090149554 Water-soluble metal alcoholate derivatives, production methods thereof, and solid gelatinous external preparations containing the same |
| 06/11/2009 | US20090149553 Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects |
| 06/11/2009 | US20090149543 Solid pharmaceutical compositions comprising lumiracoxib |
| 06/11/2009 | US20090149537 Use of Bile Acid or Bile Salt Fatty Acid Conjugates |
| 06/11/2009 | US20090149473 Topical antifungal composition |
| 06/11/2009 | US20090149453 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 06/11/2009 | US20090149412 Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart Failure |
| 06/11/2009 | US20090149411 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 06/11/2009 | US20090149408 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; inflammatory, respiratory, proliferative, autoimmune, cardiovascular diseases |
| 06/11/2009 | US20090149392 Abuse-resistant amphetamine prodrugs |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149388 Dried blood factor composition comprising trehalose |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148533 Ion binding compositions |
| 06/11/2009 | US20090148531 Rate-controlled particles |
| 06/11/2009 | US20090148517 Melt-extrusion multiparticulates |
| 06/11/2009 | US20090148511 Composition and method for dermatological treatment |
| 06/11/2009 | US20090148499 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 06/11/2009 | US20090148495 Optimum Density Fibrous Matrix |
| 06/11/2009 | US20090148459 Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents |
| 06/11/2009 | US20090148434 Antibody Compositions and Methods |
| 06/11/2009 | US20090148406 Stable Aqueous Systems Comprising Proteins |
| 06/11/2009 | US20090148397 Compositions and Methods of Treatment With Proanthocyanidin Polymer Antidiarrheal Compositions |
| 06/11/2009 | CA2708223A1 Oral compositions of abt-263 for treating cancer |
| 06/11/2009 | CA2708153A1 Carbohydrate conjugates as delivery agents for oligonucleotides |
| 06/11/2009 | CA2708064A1 Edible film |
| 06/11/2009 | CA2707666A1 Systems and methods for delivery of materials |
| 06/11/2009 | CA2707443A1 Conjugates of anti-rg-1 antibodies |
| 06/11/2009 | CA2707201A1 G immunoglobulin used against anthrax toxins |
| 06/11/2009 | CA2707060A1 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 06/11/2009 | CA2706926A1 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 06/11/2009 | CA2706923A1 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 06/11/2009 | CA2706914A1 Biocompatible biodegradable fumagillin analog conjugates |
| 06/10/2009 | EP2067792A2 Inhibitory antibodies of HER3 activity |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067487A2 Immunomodulatory formulations and methods for use thereof |
| 06/10/2009 | EP2067484A2 Method for producing insulin in the form of an oral preparation |
| 06/10/2009 | EP2067475A1 Tacrolimus sustained-release preparation |
| 06/10/2009 | EP2067472A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/10/2009 | EP2067468A1 Sustained release dosage forms of anesthetics for pain management |
| 06/10/2009 | EP2066705A1 Cationic polymers as thickeners for aqueous and alcoholic compositions |
| 06/10/2009 | EP2066703A1 Formulations and composites with reactive fillers |
| 06/10/2009 | EP2066700A1 Dextran functionalized with hydrophobic amino acids |
| 06/10/2009 | EP2066348A1 Compositions and methods for enhancing an adjuvant |
| 06/10/2009 | EP2066341A1 Method of eliciting or inducing an immune response |
| 06/10/2009 | EP2066336A2 Use of pegylated il-10 to treat cancer |
| 06/10/2009 | EP2066330A2 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 06/10/2009 | EP2066321A2 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 06/10/2009 | EP2066313A2 Topical compositions |
| 06/10/2009 | EP2066310A1 Emulsions comprising rubber arabicum |
| 06/10/2009 | EP2066305A2 Polymer matrix, method for its production, and its use |
| 06/10/2009 | EP2066302A2 Stabilizing compositions for antibiotics and methods of use |
| 06/10/2009 | EP2066301A1 Injectable pharmaceutical nimesulide solutions |
| 06/10/2009 | EP2066300A2 Self-preserved aqueous pharmaceutical compositions |
| 06/10/2009 | EP1802347B1 Anti-snoring composition |
| 06/10/2009 | EP1385490B1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 06/10/2009 | EP1352070B1 A fibrin/fibrinogen-binding conjugate |
| 06/10/2009 | EP1289573B1 A medicinal aerosol antidiabetics formulation |
| 06/10/2009 | EP0732924B1 Tts containing a parasympathomimetic and a parasympatholytic agent |
| 06/10/2009 | DE102004042139B4 Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit Oral dosage forms for obtaining a Retardierungseffektes after drug intake with a meal |
| 06/10/2009 | CN101450215A Polylactic acid-glycolic acid co-polymer nanometer granule with immunotoxin out-connection antibody inside |
| 06/10/2009 | CN101450214A Transferrin-frog-egg ribonuclease coupler and production method and use thereof |